People · Operator
Named in public records as an officer, director or promoter · active 2011–2020 · Other Technology, Other, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Pathology Watch Inc. | — | Other Technology | Series B | $28.9M | $402.6M | 2019 |
| Owlstone Inc. | — | Other | Seed | $9.4M | $5.5M | 2011 |
| TheraPten Biosciences Inc. | — | Biotechnology | Seed | $2.0M | $66.6M | 2018 |
Yiannis Monovoukas at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Yiannis Monovoukas on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Mark Brennan | 1 | 12 |
| Rick Stratford | 1 | 7 |
| Austin Walters | 1 | 4 |
| Thomas Finn | 1 | 3 |
| Harvey Lalach | 1 | 3 |
| Bret Bader | 1 | 2 |
| Daniel Lambert | 1 | 2 |
| THOMAS P FINN | 1 | 2 |
| Scott Mattivi | 1 | 1 |
| Michael Torno | 1 | 1 |
| Arjun Desai | 1 | 1 |
| Gregory Osmond | 1 | 1 |
| Athanasios Alevizopoulos | 1 | 1 |
| Harvey Lach | 1 | 1 |
| Kyriakoulis Paganis | 1 | 1 |
| Ashley Boone | 1 | 1 |
| David Ruiz-Alonso | 1 | 1 |
| Andrew Koehl | 1 | 1 |
| Paul Boyle | 1 | 1 |
| H SHEPARD BOONE | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.